tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Elekta to Present Q2 2025/26 Financial Results

Story Highlights
  • Elekta is a leader in precision radiation therapy, offering innovative cancer care solutions.
  • Elekta’s Q2 2025/26 financial results will be presented on November 26, providing key insights for stakeholders.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Elekta to Present Q2 2025/26 Financial Results

TipRanks Cyber Monday Sale

Elekta AB ( ($SE:EKTA.B) ) has shared an update.

Elekta AB has announced a presentation of its second quarter 2025/26 financial results, scheduled for November 26. The event will feature insights from the company’s President and CEO, Jakob Just-Bomholt, and CFO, Tobias Hägglöv, and will include a live webcast and Q&A session. This presentation is significant for stakeholders as it provides an opportunity to gain insights into Elekta’s operational performance and strategic direction.

The most recent analyst rating on ($SE:EKTA.B) stock is a Hold with a SEK43.00 price target. To see the full list of analyst forecasts on Elekta AB stock, see the SE:EKTA.B Stock Forecast page.

More about Elekta AB

Elekta is a leader in precision radiation therapy, dedicated to providing access to top-tier cancer care. The company collaborates with customers to develop sustainable and cost-efficient solutions aimed at improving patient outcomes and enhancing lives. Headquartered in Stockholm, Sweden, Elekta operates in over 40 countries and is listed on Nasdaq Stockholm.

Average Trading Volume: 1,162,036

Technical Sentiment Signal: Sell

Current Market Cap: SEK16.62B

See more data about EKTA.B stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1